Intact Therapeutics
YC W19San Francisco, US · Founded 2015 · 4 employees · 5 known investors
Find your way into Intact Therapeutics
Sign up to see every warm intro you have to Intact Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Intact Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Intact Therapeutics is developing an advanced materials platform that uses smart gels to deliver and absorb drugs locally within the digestive tract. The company aims to improve treatment for a range of gastrointestinal disorders.
Founders & leadership· Y Combinator alumni (W19)
Intact Therapeutics was founded in 2015 by Ravi Pamnani and Sidhartha Sinha.
Investors · 5
How we know: Brightstone Venture Capital's portfolio page · open dataset · 5k.vc investor directory · Y Combinator's founder network · Not right? Tell us
How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
Related companies · 9
Companies working in the same space as Intact Therapeutics.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $296.5K |
| National Science Foundation | Phase I | 2020 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Legal entities · 1
corporate structureFrequently asked questions
- What does Intact Therapeutics do?
- Intact Therapeutics is developing an advanced materials platform that uses smart gels to deliver and absorb drugs locally within the digestive tract. The company aims to improve treatment for a range of gastrointestinal disorders.
- Who founded Intact Therapeutics?
- Intact Therapeutics was founded by Ravi Pamnani, Sidhartha Sinha in 2015.
- Who are Intact Therapeutics's investors?
- Intact Therapeutics's investors include Brightstone Venture Capital, Y Combinator, Hanmi Healthcare, Stanford University, Venture Investment Associates.
- Where is Intact Therapeutics headquartered?
- Intact Therapeutics is headquartered in San Francisco, US.









